Delivery Order SPE2DB22D1017-SPE2DB25FG9EL
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $10,541.99 to AmerisourceBergen Drug Corp for TRIUMEQ 600-50-300 mg tablets (30-count units) on September 5, 2025, with completion scheduled for September 8, 2025. This firm fixed-price delivery order was competitively awarded with no set-aside designation and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. TRIUMEQ is an antiretroviral combination therapy used for HIV treatment,...
- The Defense Logistics Agency awarded a delivery order valued at $14,373.49 to AmerisourceBergen Drug Corp for TRIUMEQ 600-50-300 mg tablets (30-count unit dose packaging) on August 11, 2025, with completion scheduled for August 12, 2025. This firm fixed-price delivery order represents a non-set-aside competitive award to the pharmaceutical distributor's Corporate Office located in Conshohocken, Pennsylvania. TRIUMEQ is a combination antiretroviral medication used in HIV treatment, reflecting the...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp on July 31, 2025, for the supply of TRIUMEQ 600-50-300 mg tablets in quantities of 30 units. This firm fixed-price delivery order carries a ceiling value of $27,001.31 and is scheduled for completion by August 1, 2025. The contract was competitively awarded with no set-aside designation and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. TRIUMEQ is an...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 17, 2025, for the supply of TRIUMEQ 600-50-300 mg tablets in units of 30, with a ceiling value of $8,765.93. This contract represents a firm fixed-price delivery order with no set-aside designation, indicating competitive award. The order is scheduled for ultimate completion on July 18, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. As a...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for TRIUMEQ 600-50-300 mg tablets (30-count units) on January 2, 2026, with a ceiling value of $7,589.09 and ultimate completion date of January 5, 2026. This firm fixed-price delivery order was competitively awarded with no set-aside designation and will be performed at the contractor's Conshohocken, Pennsylvania facility. TRIUMEQ is an antiretroviral combination medication used in HIV treatment and management....
- The Defense Logistics Agency awarded a delivery order valued at $12.5K to AmerisourceBergen Drug Corp for TRIUMEQ 600-50-300 mg tablets (30-count units) on July 25, 2025, with an ultimate completion date of July 28, 2025. This competitively awarded, firm fixed-price contract is being performed at the vendor's corporate office location in Conshohocken, Pennsylvania. TRIUMEQ is a combination antiretroviral medication used in HIV treatment, reflecting the Defense Logistics Agency Medical Supply...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 31, 2025, for the supply of TRIUMEQ 600-50-300 mg tablets in quantities of 30 units. This is a firm fixed price delivery order with a ceiling value of $4,166.96 and an ultimate completion date of August 1, 2025. The contract does not utilize a set-aside designation and will be performed at the vendor's Conshohocken, Pennsylvania location. This delivery order is issued under AmerisourceBergen Drug...
- The Defense Logistics Agency awarded a delivery order valued at $8,910.52 to AmerisourceBergen Drug Corp for the supply of TRIUMEQ 600-50-300 mg tablets (30-count units) on September 4, 2025, with completion expected by September 5, 2025. This firm fixed-price delivery order represents a non-competitive, non-set-aside award and falls under the company's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated as SPE2DX and valued at $999,999,999.00 through December...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on December 17, 2025, for the supply of TRIUMEQ 600-50-300 mg tablets in quantities of 30 units. This is a firm fixed-price contract with a ceiling value of $6,870.93 and an ultimate completion date of December 18, 2025. The place of performance is AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. This delivery order was not set aside and represents a competitively awarded contract,...
- The Defense Logistics Agency awarded a delivery order valued at $254,762.50 to AmerisourceBergen Drug Corp for the supply of TRIUMEQ 600-50-300 mg tablets in quantities of 30 units. This is a competitively awarded, firm fixed-price delivery order with no set-aside designation, with an ultimate completion date of December 24, 2025. The contract will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. TRIUMEQ is an antiretroviral medication used in the...
- SPE2DB22D1017Indefinite Delivery Contract
- SPE2DB22D1017-SPE2DB25FG9ELDelivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 7, 2025, for the supply of TRIUMEQ 600-50-300 mg tablets in quantities of 30 units. This delivery order, valued at $12,117.72, represents a firm fixed price contract with no set-aside designation, reflecting a competitively awarded transaction under open procurement standards. The contract is scheduled for ultimate completion on August 8, 2025, with performance taking place at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. TRIUMEQ is a combination antiretroviral medication used in HIV treatment, and this order supports the Defense Logistics Agency's Medical Supply Chain operations. This delivery order is issued under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), which carries a ceiling value of $999,999,999.00 and extends through December 2026. This prime contract vehicle enables AmerisourceBergen to serve as a global pharmaceutical supplier to military healthcare programs, the Defense Health Agency, U.S. Coast Guard, and other federal healthcare systems. The company's extensive portfolio of federal awards demonstrates its established capability to fulfill diverse pharmaceutical and medical supply requirements across multiple therapeutic domains through competitively awarded delivery orders with consistent firm fixed pricing structures.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $12.1k | 8/7/25 |